SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11216930
Source:
http://linkedlifedata.com/resource/pubmed/id/11216930
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001675
,
umls-concept:C0023983
,
umls-concept:C0033107
,
umls-concept:C0041296
,
umls-concept:C0599755
pubmed:issue
2
pubmed:dateCreated
2001-2-16
pubmed:abstractText
To determine the long-term effect of preventive therapy (PT) for tuberculosis on the rates of tuberculosis, mortality and HIV progression.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Isoniazid
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazinamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Rifampin
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0269-9370
pubmed:author
pubmed-author:FuchsDD
,
pubmed-author:Godfrey-FaussettPP
,
pubmed-author:HospMM
,
pubmed-author:LisseII
,
pubmed-author:MwingaAA
,
pubmed-author:Porter JDH
,
pubmed-author:QuigleyM AMA
pubmed:issnType
Print
pubmed:day
26
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
215-22
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11216930-AIDS-Related Opportunistic Infections
,
pubmed-meshheading:11216930-Adult
,
pubmed-meshheading:11216930-Antitubercular Agents
,
pubmed-meshheading:11216930-CD4 Lymphocyte Count
,
pubmed-meshheading:11216930-Cohort Studies
,
pubmed-meshheading:11216930-Disease Progression
,
pubmed-meshheading:11216930-Female
,
pubmed-meshheading:11216930-Follow-Up Studies
,
pubmed-meshheading:11216930-HIV Infections
,
pubmed-meshheading:11216930-Humans
,
pubmed-meshheading:11216930-Isoniazid
,
pubmed-meshheading:11216930-Male
,
pubmed-meshheading:11216930-Pyrazinamide
,
pubmed-meshheading:11216930-Rifampin
,
pubmed-meshheading:11216930-Time Factors
,
pubmed-meshheading:11216930-Treatment Outcome
,
pubmed-meshheading:11216930-Tuberculosis
,
pubmed-meshheading:11216930-Zambia
pubmed:year
2001
pubmed:articleTitle
Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults.
pubmed:affiliation
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't